Cargando…
Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"
Drug coverage in Canada is a patchwork; an inequitable inefficient and unsustainable patchwork with no coherence or purpose. Some people think that we can solve the problem by adding more patches, but the core of the problem is that it is a patchwork. For the working population, access to medicines...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kerman University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947898/ https://www.ncbi.nlm.nih.gov/pubmed/32610789 http://dx.doi.org/10.34172/ijhpm.2020.40 |
_version_ | 1783663323431043072 |
---|---|
author | Gagnon, Marc-André |
author_facet | Gagnon, Marc-André |
author_sort | Gagnon, Marc-André |
collection | PubMed |
description | Drug coverage in Canada is a patchwork; an inequitable inefficient and unsustainable patchwork with no coherence or purpose. Some people think that we can solve the problem by adding more patches, but the core of the problem is that it is a patchwork. For the working population, access to medicines is still organized as privileges offered by employers to their employees. Universal pharmacare would not only provide better access to needed prescription drugs, but also eliminate waste, ensure value-for-money and help improve drug safety and appropriate prescribing. Opponents fear that a universal pharmacare plan would ration drugs, and impede drug access for some patients. However, these claims misunderstand the reality of drug coverage, pricing and access. Opponents propose, instead, to "fill the gap" of current drug coverage by implementing catastrophic coverage, which would serve commercial interests without maximizing health outcomes for the Canadian population. In spite of overwhelming evidence and consensus in the academic community in favour of universal pharmacare, the battle is far from over. |
format | Online Article Text |
id | pubmed-7947898 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Kerman University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-79478982021-03-16 Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada" Gagnon, Marc-André Int J Health Policy Manag Commentary Drug coverage in Canada is a patchwork; an inequitable inefficient and unsustainable patchwork with no coherence or purpose. Some people think that we can solve the problem by adding more patches, but the core of the problem is that it is a patchwork. For the working population, access to medicines is still organized as privileges offered by employers to their employees. Universal pharmacare would not only provide better access to needed prescription drugs, but also eliminate waste, ensure value-for-money and help improve drug safety and appropriate prescribing. Opponents fear that a universal pharmacare plan would ration drugs, and impede drug access for some patients. However, these claims misunderstand the reality of drug coverage, pricing and access. Opponents propose, instead, to "fill the gap" of current drug coverage by implementing catastrophic coverage, which would serve commercial interests without maximizing health outcomes for the Canadian population. In spite of overwhelming evidence and consensus in the academic community in favour of universal pharmacare, the battle is far from over. Kerman University of Medical Sciences 2020-03-14 /pmc/articles/PMC7947898/ /pubmed/32610789 http://dx.doi.org/10.34172/ijhpm.2020.40 Text en © 2021 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Gagnon, Marc-André Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada" |
title | Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada" |
title_full | Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada" |
title_fullStr | Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada" |
title_full_unstemmed | Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada" |
title_short | Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada" |
title_sort | understanding the battle for universal pharmacare in canada comment on "universal pharmacare in canada" |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947898/ https://www.ncbi.nlm.nih.gov/pubmed/32610789 http://dx.doi.org/10.34172/ijhpm.2020.40 |
work_keys_str_mv | AT gagnonmarcandre understandingthebattleforuniversalpharmacareincanadacommentonuniversalpharmacareincanada |